{"id":82236,"date":"2017-07-05T11:13:03","date_gmt":"2017-07-05T11:13:03","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=a4ced85b9c3a5ea59c5c689fdecb183b"},"modified":"2017-07-05T11:13:03","modified_gmt":"2017-07-05T11:13:03","slug":"news-story-nasal-decongestant-to-be-available-to-buy-from-pharmacies","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=82236","title":{"rendered":"News story: Nasal decongestant to be available to buy from pharmacies"},"content":{"rendered":"<div class=\"govspeak\">\n<p>The Medicines and Healthcare products Regulatory Agency has today agreed that Otrivine Extra Dual Relief Nasal Spray Solution will be available through pharmacies without prescription.<\/p>\n<p>Otrivine Extra Dual Relief Nasal Spray contains Ipratropium bromide 0.6mg\/ml and xylometazoline hydrochloride 0.5mg\/ml.<\/p>\n<p>Following a public consultation, MHRA has agreed to reclassify Otrivine Extra Dual Relief Nasal Spray Solution from a Prescription Only Medicine (POM) to a Pharmacy (P) medicine in the UK for the symptomatic treatment of nasal congestion and rhinorrhoea in connection with common colds.<\/p>\n<p>MHRA is committed to improving access to medicines where it is safe to do so, providing greater choice and better access for the public.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MHRA reclassifies Otrivine Extra Dual Relief Nasal Spray Solution<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/82236"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=82236"}],"version-history":[{"count":0,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/82236\/revisions"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=82236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=82236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=82236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}